PILMAN- A Tapan Ray Website on Healthcare

April 17, 2017

By Tapan Ray

The prices of new cancer drugs are increasingly becoming unsustainable across the world, and more so in India. A sizable number of poor and even middle-income patients, who spend their entire life’s savings for the treatment of this dreaded disease, is pushed towards extreme economic hardship. Their plight in India would continue to remain so, till Universal Health Care (UHC) comes into force, as enunciated in the National Health Policy 2017.

Thus, the delivery of affordable and equitable cancer care poses one of India’s greatest public health challenges. Public expenditure on cancer in India remains below US$ 10 per person, as compared with more than US$ 100 per person in high-income countries. The May 2014 paper, published in ‘The Lancet Oncology’, analyzed this concern in detail.

Read the full article

Sign up for our eNewsletter today!

 

First Name




Search

Cures Within Reach

info@cureswithinreach.org

 

Thursday the 14th. copyright 2015 Cures Within Reach.